Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML. (Q40631359)
Jump to navigation
Jump to search
scientific article published on September 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML. |
scientific article published on September 1999 |
Statements
1 reference
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML. (English)
1 reference
H T Steinmetz
1 reference
A Schulz
1 reference
P Staib
1 reference
C Scheid
1 reference
A Glasmacher
1 reference
A Neufang
1 reference
J Franklin
1 reference
H Tesch
1 reference
V Diehl
1 reference
P Dias Wickramanayake
1 reference
1 September 1999
1 reference
1 reference
78
1 reference
9
1 reference
418-425
1 reference
Identifiers
1 reference
1 reference